跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial
Approved
STANDARD
HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial
Eisai Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
933c42ee4ace14ba
Company
Eisai Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
933c42ee4ace14ba
Product Name
HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial
Artg Id
187136
Artg Name
HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial
Sponsor
Eisai Australia Pty Ltd
Company Detail Path
/organization/eisai-australia-pty-ltd
Artg Date
2012-09-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d4478ad23321708204fb699d0597b769.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1088876fa07b255878441e172cecc651.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
933c42ee4ace14ba
Type
Standard
Back to TGA Approvals
HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial - TGA Drug Approval Details